Literature DB >> 16376884

Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation.

B Lambert1, M Buckle.   

Abstract

We have used surface plasmon resonance to quantify the kinetics and stoichiometry of the interaction between p53 and nucleophosmin (NPM). Domains characterising the interface between the two proteins were identified by chemical cross-linking, proteolytic digestion and mass spectrometry based peptide mapping. We show that the C-terminal domain of NPM (residues 242-269) interacts with two regions of p53 (residues 175-196 and residues 343-363) which belong, respectively, to the DNA binding domain and the tetramerisation domain. Potential biological consequences of such interactions are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16376884     DOI: 10.1016/j.febslet.2005.12.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.

Authors:  Erin M Swaney; Anuja Chattopadhyay; Irina Abecassis; Elizabeth A Rush; Robert L Redner
Journal:  Leuk Lymphoma       Date:  2016-01-12

2.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

3.  Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.

Authors:  S Lee; J-Y Kim; Y-J Kim; K-O Seok; J-H Kim; Y-J Chang; H-Y Kang; J-H Park
Journal:  Cell Death Differ       Date:  2012-04-20       Impact factor: 15.828

4.  Cytoplasmic p53 and activated Bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis.

Authors:  Ying Geng; K C Walls; Arindam P Ghosh; Rizwan S Akhtar; Barbara J Klocke; Kevin A Roth
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

5.  Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation.

Authors:  Jian Tang; Jing-Wen Niu; Dong-Hui Xu; Zhi-Xing Li; Qi-Fu Li; Jin-An Chen
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

6.  Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation.

Authors:  Rachel McCloskey; Craig Menges; Alan Friedman; Daksha Patel; Dennis J McCance
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

7.  Intrinsically disordered regions of nucleophosmin/B23 regulate its RNA binding activity through their inter- and intra-molecular association.

Authors:  Miharu Hisaoka; Kyosuke Nagata; Mitsuru Okuwaki
Journal:  Nucleic Acids Res       Date:  2013-10-07       Impact factor: 16.971

8.  Dynamic conformations of nucleophosmin (NPM1) at a key monomer-monomer interface affect oligomer stability and interactions with granzyme B.

Authors:  Wei D Duan-Porter; Virgil L Woods; Kimberly D Maurer; Sheng Li; Antony Rosen
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

Review 9.  Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.

Authors:  Ilaria Moscetti; Salvatore Cannistraro; Anna Rita Bizzarri
Journal:  Sensors (Basel)       Date:  2017-11-20       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.